Rigel Pharmaceuticals | RIGL - Lngresos Netos





Lngresos Netos Cambio Fecha
Agenus USD 39.17M 49.8M 2026-03
Amgen USD 2.38B 556M 2026-06
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -194.28M 61.55M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Celldex Therapeutics USD -73.5M 5.18M 2026-06
Daiichi Sankyo JPY 68.64B 18B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Ligand Pharmaceuticals USD 48.51M 61.85M 2026-06
MacroGenics USD -36.77M 22.62M 2026-03
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Pfizer USD -248M 2.94B 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Veracyte USD 25.49M 3.22M 2026-06